BlackRock Japan’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$4K Sell
156
-220
-59% -$6.42K ﹤0.01% 1266
2016
Q3
$16K Sell
376
-333
-47% -$43K ﹤0.01% 1151
2016
Q2
$103K Sell
709
-96
-12% -$11K ﹤0.01% 896
2016
Q1
$83K Sell
805
-26
-3% -$2.79K ﹤0.01% 944
2015
Q4
$139K Sell
831
-99
-11% -$15.2K ﹤0.01% 861
2015
Q3
$132K Buy
930
+758
+441% +$170K ﹤0.01% 834
2015
Q2
$38K Buy
172
+89
+107% +$15.6K ﹤0.01% 1113
2015
Q1
$14K Buy
+83
New +$13.5K ﹤0.01% 1215
2013
Q4
– Sell
-1,640
Closed -$103K – 1396
2013
Q3
$103K Sell
1,640
-925
-36% -$52.1K ﹤0.01% 1004
2013
Q2
$105K Buy
+2,565
New +$111K ﹤0.01% 973

Other funds holding NVAX

BlackRock Japan's NVAX Position: Q4 2016 in Review

BlackRock Japan reduced its Novavax (NVAX) stake by 59% in Q4 2016, selling an estimated $6.42K and leaving 156 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #1266.

BlackRock Japan first reported a position in NVAX in Q2 2013 and has held it in 10 quarters since. The position peaked at $139K in Q4 2015. 143 funds tracked by Wall St. Rank hold NVAX as of Q4 2016.

  • BlackRock Japan held 156 shares of Novavax worth $4K as of Q4 2016.
  • BlackRock Japan sold 220 Novavax shares in Q4 2016, an estimated $6.42K.
  • Novavax made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1266 holding.
  • BlackRock Japan first reported a position in Novavax in Q2 2013 and has held it in 10 quarters since.
  • BlackRock Japan's Novavax position peaked at $139K in Q4 2015.
  • 143 funds tracked by Wall St. Rank held Novavax as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.